An Open Label Phase II Study of First-Line Maintenance Enzalutamide Following Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Castration-Naive Prostatic Adenocarcinoma
Condition:   Prostatic Adenocarcinoma Intervention:   Drug: Enzalutamide Sponsor:   Samsung Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials

A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Condition:   Carcinoma, Non-Small-Cell Lung Interventions:   Drug: SGN-B6A;   Drug: docetaxel Sponsor:   Seagen Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials